Toward An Effective Treatment For Spinal Muscular Atrophy

Scientists are reporting a key advance toward developing the first effective drug treatment for spinal muscular atrophy (SMA), a genetic disease that involves motor neuron loss and occurs in 1 out of every 6,000 births. SMA is the leading cause of hereditary infant death in the United States.

Read the whole article on Science Daily

More from Science Daily